Online ISSN: 2515-8260

Keywords : Antimalarial


AWARENESS AND KNOWLEDGE OF HYDROXYCHLOROQUINE AMONG PUBLIC

A.Sankari Niveditha; Lakshminarayanan Arivarasu

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 1, Pages 476-485

The aim of the study is to create awareness and knowledge of Hydroxychloroquine among the general public. Hydroxychloroquine (CHQ) was first recognized as a potent antimalarial agent. It was used for the prevention and treatment of acute attacks of malaria. Hydroxychloroquine is FDA-approved to prevent and treat malaria and also to treat the autoimmune disease, rheumatoid arthritis and lupus. Quine advanced forms are chloroquine and hydroxychloroquine used for antimalarial treatment. Hydroxychloroquine has immunomodulatory effects and it may cause retinopathy. A survey was conducted among the general public during the pandemic COVID 19. The study setting was an online setting with a varied population. The sample size included 100 people and predominantly were South Indian population. The sampling method was a simple randomized method. Both the gender were included and the population was above 18 years. From the study, we come to know that 55% of people are aware of the drug hydroxychloroquine. 47% of the people were aware of the side effects of the drug hydroxychloroquine. 92% of people had knowledge about India exploring drugs to foriegn nations. 91% of people agreed that hydroxychloroquine along with common antibiotics can be used for the treatment of COVID 19. 43% of people are aware of the contraindications of the drug. Hydroxychloroquine and chloroquine can cause abnormal heart rhythms such as QT interval prolongation and rapid heart rate called ventricular tachycardia. Patients with other health issues are at higher risk when receiving these medications. Hence from the study we can conclude that the study population has only minimum knowledge and awareness about the drug hydroxychloroquine. This study helps in improving the knowledge and creating awareness among the people.